3672

541540

SOLARA

img img img img
No Data Available

SOLARA ACTIVE PHA SCI LTD Share Price Update

As of the latest trading session, SOLARA ACTIVE PHA SCI LTD is trading at ₹549.65, up by ₹16.95 or 3.18% from its previous close. The stock has moved between ₹530.30 and ₹583.00 today. Over the past year, the stock has delivered a return of 10.69%. In the last month, it has returned 8.54%.

SOLARA ACTIVE PHA SCI LTD performance

Today’s low Today’s high
₹ 530.30 ₹ 583.00
₹ 562.55
52 week low 52 week high
₹ 422.00 ₹ 734.40
₹ 562.55
Open Price ₹ 532.70
Prev. Close ₹ 532.70
Volume (Shares) 249519.00
Total traded value ₹ 1403.66
Upper Circuit ₹ 639.20
Lower Circuit ₹ 426.20
info

Investment Returns

Over 1 Month 8.54% Over 3 Months 15.46% Over 6 Months 2.44% Over 1 Year 10.69%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SOLARA ACTIVE PHA SCI LTD fundamentals


  • Market cap (Cr) 2,684.00
  • P/E Ratio (TTM) -350.89
  • Beta 0.84
  • Book Value / share 263.80
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 9.73
info icon alternate text
  • Market cap (Cr) 2,617.70
  • P/E Ratio (TTM) -350.89
  • Beta 0.75
  • Book Value / share 263.80
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 9.73
info icon alternate text

SOLARA ACTIVE PHA SCI LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 387.29
Operating Expense 382.84
Net Profit 9.73
Net Profit Margin (%) 2.51
Earnings Per Share (EPS) 2.23
EBITDA 62.83
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 349.00
Operating Expense 359.67
Net Profit -17.42
Net Profit Margin (%) -4.99
Earnings Per Share (EPS) -3.97
EBITDA 30.59
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 313.54
Operating Expense 324.10
Net Profit -10.08
Net Profit Margin (%) -3.21
Earnings Per Share (EPS) -2.36
EBITDA 35.23
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 319.15
Operating Expense 309.59
Net Profit 10.53
Net Profit Margin (%) 3.29
Earnings Per Share (EPS) 2.46
EBITDA 58.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 273.01
Operating Expense 283.84
Net Profit -4.88
Net Profit Margin (%) -1.78
Earnings Per Share (EPS) -1.65
EBITDA 48.54
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 1368.98
Operating Expense 1376.22
Net Profit -7.24
Net Profit Margin (%) -0.52
Earnings Per Share (EPS) -1.64
EBITDA 186.68
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 1283.76
Operating Expense 1293.98
Net Profit -1.08
Net Profit Margin (%) -0.08
Earnings Per Share (EPS) -0.27
EBITDA 212.98
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1288.92
Operating Expense 1592.98
Net Profit -566.87
Net Profit Margin (%) -43.98
Earnings Per Share (EPS) -157.48
EBITDA -279.33
Effective Tax Rate (%) -16.08
Particulars MAR 2023 (Values in Cr)
Revenue 1443.81
Operating Expense 1510.73
Net Profit -22.21
Net Profit Margin (%) -1.53
Earnings Per Share (EPS) -6.17
EBITDA 156.18
Effective Tax Rate (%) 50.40
Particulars MAR 2022 (Values in Cr)
Revenue 1268.34
Operating Expense 1375.27
Net Profit -58.56
Net Profit Margin (%) -4.61
Earnings Per Share (EPS) -16.29
EBITDA 95.62
Effective Tax Rate (%) 36.11
Particulars MAR 2025 (Values in Cr)
Book Value / Share 271.86
ROE % 0.05
ROCE % 5.41
Total Debt to Total Equity 0.89
EBITDA Margin 16.72
Particulars MAR 2024 (Values in Cr)
Book Value / Share 259.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.83
EBITDA Margin -7.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 416.73
ROE % -1.47
ROCE % 1.74
Total Debt to Total Equity 0.68
EBITDA Margin 10.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share 423.57
ROE % -3.74
ROCE % -0.65
Total Debt to Total Equity 0.53
EBITDA Margin 7.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 442.12
ROE % 16.55
ROCE % 14.72
Total Debt to Total Equity 0.50
EBITDA Margin 25.64
Particulars MAR 2025 (Values in Cr)
Book Value / Share 272.35
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.89
EBITDA Margin 16.59
Particulars MAR 2024 (Values in Cr)
Book Value / Share 260.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.83
EBITDA Margin -6.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 417.54
ROE % -1.47
ROCE % 1.74
Total Debt to Total Equity 0.68
EBITDA Margin 10.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 424.18
ROE % -3.75
ROCE % -0.67
Total Debt to Total Equity 0.53
EBITDA Margin 7.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 443.30
ROE % 16.47
ROCE % 14.66
Total Debt to Total Equity 0.50
EBITDA Margin 25.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.11
Total Assets 2231.84
Total Liabilities 2231.84
Total Equity 1096.91
Share Outstanding 4
Price to Book Ratio 1.88
Return on Assets (%) 0.02
Return on Capital (%) 0.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.60
Total Assets 2350.96
Total Liabilities 2350.96
Total Equity 936.58
Share Outstanding 3
Price to Book Ratio 1.43
Return on Assets (%) -24.13
Return on Capital (%) -29.31
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.89
Total Assets 2899.28
Total Liabilities 2899.28
Total Equity 1502.45
Share Outstanding 3
Price to Book Ratio 0.79
Return on Assets (%) -0.76
Return on Capital (%) -0.89
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.25
Total Assets 2944.96
Total Liabilities 2944.96
Total Equity 1527.18
Share Outstanding 3
Price to Book Ratio 1.57
Return on Assets (%) -1.97
Return on Capital (%) -2.28
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 198.54
Total Assets 2613.58
Total Liabilities 2613.58
Total Equity 1592.77
Share Outstanding 3
Price to Book Ratio 3.15
Return on Assets (%) 8.47
Return on Capital (%) 10.07
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.97
Total Assets 2225.10
Total Liabilities 2225.10
Total Equity 1096.21
Share Outstanding 4
Price to Book Ratio 1.88
Return on Assets (%) -0.04
Return on Capital (%) -0.06
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.48
Total Assets 2346.60
Total Liabilities 2346.60
Total Equity 937.42
Share Outstanding 3
Price to Book Ratio 1.43
Return on Assets (%) -24.15
Return on Capital (%) -29.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.71
Total Assets 2894.95
Total Liabilities 2894.95
Total Equity 1503.13
Share Outstanding 3
Price to Book Ratio 0.79
Return on Assets (%) -0.76
Return on Capital (%) -0.89
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.14
Total Assets 2937.44
Total Liabilities 2937.44
Total Equity 1527.05
Share Outstanding 3
Price to Book Ratio 1.57
Return on Assets (%) -1.99
Return on Capital (%) -2.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 198.38
Total Assets 2610.17
Total Liabilities 2610.17
Total Equity 1592.79
Share Outstanding 3
Price to Book Ratio 3.15
Return on Assets (%) 8.46
Return on Capital (%) 10.05
Particulars MAR 2025 (Values in Cr)
Net Income 0.54
Cash from Operations 213.72
Cash from Investing -36.83
Cash from Financing -180.48
Net change in Cash -4.49
Free Cash Flow 253.66
Particulars MAR 2024 (Values in Cr)
Net Income -488.42
Cash from Operations 107.97
Cash from Investing -3.51
Cash from Financing -105.65
Net change in Cash -0.29
Free Cash Flow 149.03
Particulars MAR 2023 (Values in Cr)
Net Income -44.82
Cash from Operations 142.71
Cash from Investing -81.14
Cash from Financing -112.76
Net change in Cash -37.65
Free Cash Flow 254.02
Particulars MAR 2022 (Values in Cr)
Net Income -91.10
Cash from Operations -223.93
Cash from Investing -242.85
Cash from Financing 333.57
Net change in Cash -151.31
Free Cash Flow -15.31
Particulars MAR 2021 (Values in Cr)
Net Income 221.50
Cash from Operations 188.82
Cash from Investing -106.30
Cash from Financing 92.49
Net change in Cash 141.65
Free Cash Flow 363.29
Particulars MAR 2025 (Values in Cr)
Net Income -1.08
Cash from Operations 213.70
Cash from Investing -36.83
Cash from Financing -180.48
Net change in Cash -4.51
Free Cash Flow 253.64
Particulars MAR 2024 (Values in Cr)
Net Income -488.33
Cash from Operations 110.03
Cash from Investing -4.66
Cash from Financing -106.52
Net change in Cash -0.23
Free Cash Flow 153.10
Particulars MAR 2023 (Values in Cr)
Net Income -44.78
Cash from Operations 142.46
Cash from Investing -81.13
Cash from Financing -112.76
Net change in Cash -37.72
Free Cash Flow 253.77
Particulars MAR 2022 (Values in Cr)
Net Income -91.66
Cash from Operations -223.72
Cash from Investing -243.08
Cash from Financing 333.59
Net change in Cash -151.26
Free Cash Flow -14.84
Particulars MAR 2021 (Values in Cr)
Net Income 220.96
Cash from Operations 187.01
Cash from Investing -105.25
Cash from Financing 92.50
Net change in Cash 141.69
Free Cash Flow 360.50
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 14.75 1.72 273.50 23.12 40.00
BLISS GVS PHARMA LTD. 424.80 34.37 3.76 4493.92 118.35 437.40
CIPLA LTD. 1398.50 27.69 3.28 112970.91 1165.55 1672.20
FERMENTA BIOTECH LTD. 295.20 13.02 2.13 868.80 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 24.96 4.59 273.50 23.12 40.00
AMRUTAJAN HEALTH LTD 559.55 25.08 4.36 1617.69 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8671.45 113.25 24.83 21678.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 424.80 45.68 3.89 4493.92 118.35 437.40

SOLARA ACTIVE PHA SCI LTD shareholding pattern

Holding
42.89%
41.99%
11.33%
3.77%
36.57%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SOLARA ACTIVE PHA SCI LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
562.55 5.60 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 546.60
  • 26 Days 529.00
  • 10 Days 546.90
  • 50 Days 513.50
  • 12 Days 545.10
  • 100 Days 513.40
  • 20 Days 535.70
  • 200 Days 534.30
551.70 PIVOT
First Support 536.45 First Resistance 561.05 Second Support 527.10 Second Resistance 576.30 Third Support 511.85 Third Resistance 585.65
RSI 51.43 ADX 57.17 MACD 16.08 Williams % R -64.54 Commodity Channel Index (CCI) 3.02
Date 2026-05-29 Week 64250.00 Same Day 69292.00 Month 83711.00
1 Year 0.84 3 Year 0.98
Over 1 Month
8.54% down
Over 1 Year
10.69% down
Over 3 Months
15.46% down
Over 3 Years
17.14% down
Over 6 Months
2.44% down
Over 5 Years
-19.94% down

SOLARA ACTIVE PHA SCI LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Aug 2021 3.0 Final 20 Aug 2021 Equity shares
19 Nov 2020 4.0 Interim 20 Nov 2020 Equity shares
28 Jul 2020 2.0 Final 30 Jul 2020 Equity shares
06 Aug 2019 5.0 Final 08 Aug 2019 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
18 Aug 2021 3.0 Final 20 Aug 2021 Equity shares
19 Nov 2020 4.0 Interim 20 Nov 2020 Equity shares
28 Jul 2020 2.0 Final 30 Jul 2020 Equity shares
06 Aug 2019 5.0 Final 08 Aug 2019 Equity shares

Top Gainers

Top Losers

Solara Active Pharma Sciences Ltd share result highlights

For Q1 of FY 25-26, the company's consolidated sales were ₹319 crore, and its net profit for the period stood at ₹11 crore. In the corresponding Q1 of FY 24-25, the sales were ₹363 crore with a net loss of ₹13 crore for the period.

Date Source: screener.in, and corporate filings on NSE/BSE

Solara Active Pharma Sciences Ltd share annual reports

For FY 24-25, the company reported consolidated sales of ₹1,284 crore and a net profit of ₹1 crore. In the preceding year, FY 23-24, the company's sales were ₹1,289 crore with the net loss of ₹567 crore.

Date Source: screener.in, and corporate filings on NSE/BSE

Solara Active Pharma Sciences Ltd share dividend

The company's stock has a face value of ₹10.0 per share and pays a dividend yield of 0.00%. The company has not declared any dividend in recent years. The last dividend of ₹3 was issued for FY 2021-22 with an ex-date of August 18, 2021.

Date Source: screener.in, and corporate filings on NSE/BSE

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Solara Active Pharma Sciences Ltd?

Answer Field

Solara Active Pharma Sciences Ltd share price is for NSE ₹ 549.65 & for BSE ₹ 548.15 as on Jun 01 2026 03:16 PM.

What is the Market Cap of Solara Active Pharma Sciences Ltd Share?

Answer Field

The market cap of Solara Active Pharma Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 01 2026 03:16 PM.

What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?

Answer Field

The 52 Week High and Low of Solara Active Pharma Sciences Ltd for NSE is ₹ 734.40 and ₹ 422.00 and for BSE is ₹ 734.20 and ₹ 422.85.

What is 1 year return for Solara Active Pharma Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 10.69%.

What is the P/E Ratio of Solara Active Pharma Sciences Ltd Share?

Answer Field

As on Jun 01 2026 03:16 PM the price-to-earnings (PE) ratio for Solara Active Pharma Sciences Ltd share is -350.89.

What is the PB ratio of Solara Active Pharma Sciences Ltd Share?

Answer Field

As on Jun 01 2026 03:16 PM, the price-to-book (PB) ratio for Solara Active Pharma Sciences Ltd share is 263.80.

How to Buy Solara Active Pharma Sciences Ltd Share?

Answer Field

You can trade in Solara Active Pharma Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Solara Active Pharma Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Solara Active Pharma Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Solara Active Pharma Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

Who is the CEO of Solara Active Pharma Sciences Ltd?

Answer Field

The CEO of Solara Active Pharma Sciences Ltd is Poorvank Purohit, who also serves as the Managing Director of the company.

When was Solara Active Pharma Sciences Ltd established?

Answer Field

Solara Active Pharma Sciences Ltd was incorporated on February 23, 2017. The company was formed from the demerger of the Active Pharmaceutical Ingredients (API) business from Strides Shasun Ltd.

What factors influence the Solara Share Price?

Answer Field

The Solara share price is influenced by factors such as financial performance, market conditions, regulatory approvals, and the global demand for active pharmaceutical ingredients. Changes in debt levels, profit margins, and strategic moves like the sale of its stake in Sequent Penems also impact its share price.

Is Solara Active Pharma Sciences Ltd debt-free?

Answer Field

No, Solara Active Pharma Sciences Ltd is not debt-free. As of March 2024, the company reported borrowings of Rs. 1,012 crores. However, it has been actively working to reduce its working capital requirements over time.

What is the CAGR of Solara Share?

Answer Field

The Compound Annual Growth Rate (CAGR) of Solara’s stock price over the past five years stands at 13%. However, the three-year CAGR is negative at -7%, reflecting a decline in the stock’s value during that period.

How has the Solara Share Price performed over the past year?

Answer Field

Over the past year, Solara’s share price has seen a significant increase, rising by 143%, demonstrating a positive market response despite challenges in revenue and profitability.

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|